Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial. - Faridar, Alireza; Gamez, Nazaret; Li, Daling; Wang, Yanling; Boradia, Reena; Thome, Aaron D.; Zhao, Weihua; Beers, David R.; Thonhoff, Jason R.; Nakawah, Mohammad O.; Román, Gustavo C.; Volpi, John J.; et al. (Alzheimer's Research & Therapy, 2025)